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Abstract
IgE antibodies and mast cells play critical roles in the establishment of allergic responses
to food antigens. Curcumin, the active ingredient of the curry spice turmeric, has anti-
inflammatory properties, and thus may have the capacity to regulate Th2 cells and mucosal
mast cell function during allergic responses. We assessed whether curcumin ingestion dur-
ing oral allergen exposure can modulate the development of food allergy using a murine
model of ovalbumin (OVA)-induced intestinal anaphylaxis. Herein, we demonstrate that fre-
quent ingestion of curcumin during oral OVA exposure inhibits the development of mastocy-
tosis and intestinal anaphylaxis in OVA-challenged allergic mice. Intragastric (i.g.) exposure
to OVA in sensitized BALB/c mice induced a robust IgE-mediated response accompanied
by enhanced OVA-IgE levels, intestinal mastocytosis, elevated serum mMCP-1, and acute
diarrhea. In contrast, mice exposed to oral curcumin throughout the experimental regimen
appeared to be normal and did not exhibit intense allergic diarrhea or a significant enhance-
ment of OVA-IgE and intestinal mast cell expansion and activation. Furthermore, allergic
diarrhea, mast cell activation and expansion, and Th2 responses were also suppressed in
mice exposed to curcumin during the OVA-challenge phase alone, despite the presence of
elevated levels of OVA-IgE, suggesting that curcumin may have a direct suppressive effect
on intestinal mast cell activation and reverse food allergy symptoms in allergen-sensitized
individuals. This was confirmed by observations that curcumin attenuated the expansion of
both adoptively transferred bone marrow-derived mast cells (BMMCs), and inhibited their
survival and activation during cell culture. Finally, the suppression of intestinal anaphylaxis
by curcumin was directly linked with the inhibition of NF-κB activation in curcumin-treated
allergic mice, and curcumin inhibited the phosphorylation of the p65 subunit of NF-κB in
BMMCs. In summary, our data demonstrates a protective role for curcumin during allergic
responses to food antigens, suggesting that frequent ingestion of this spice may modulate
the outcome of disease in susceptible individuals.
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Introduction
Food allergy is an emerging public health problem worldwide [1–4]. Severe anaphylactic reac-
tions to food products underscore the need for research to better understand the mechanisms
by which food antigens stimulate the gastrointestinal tract and impair tolerance to ingested
food particles. In addition, there is a need to develop therapeutic agents that either prevent sen-
sitization to food antigens or suppress the allergic response after initiation.
IgE and mast cells play a crucial role in the development of allergic responses to food anti-
gens [2, 5–7]. Patients with food allergies produce elevated levels of allergen-specific IgE
and exhibit both eosinophilic and mast cell inflammation in the gastrointestinal tract [7, 8].
Animal models also suggest a prominent role for mast cells and IgE, as we, and others
have previously shown [9–13]. Additionally, the allergic phenotype is driven by Th2 cells,
producing high levels of the cytokines IL-4, IL-5, IL-9, and IL-13 in the intestinal mucosa
[14, 15].
In contrast to the increased rates of food allergy in the West, the incidence of the disease
in developing countries is much lower [1]. A number of theories have been proposed to
account for this dichotomy in allergic sensitization, including differences in lifestyle, expo-
sure to pathogens, and dietary habits [8, 16–18]. Dietary components, particularly, have the
capacity to influence the mucosal immune system and modulate the allergic response. Curcu-
min (diferuloylmethane, C21H20O6) is a natural product of the spice turmeric (Curcuma
longa), and has well-known pharmacologic activities, including anti-inflammatory and anti-
oxidant properties, and has beneficial roles in diseases such as cancer[19], Alzheimer’s [20],
and diabetes [21]. Numerous studies implicate a prominent role for curcumin in regulation
of the immune system, including the modulation of T cells and mast cells [21]. Additionally,
a number of reports also suggest that curcumin possesses anti-allergic activity [22–25]. In a
model of ovalbumin (OVA)-induced asthma in guinea pigs, exposure to curcumin inhibited
bronchial constriction, and airway hyperreactivity to histamine [22]. Similarly, oral ingestion
of curcumin in a latex allergy model, diminished Th2 responses, eosinophilia, IgE produc-
tion, and lung pathology [24]. More recently, curcumin was shown to suppress the develop-
ment of Aspergillus fumigatus-induced airway inflammation, allergic rhinitis, and OVA-
induced allergic conjunctivitis as well as allergic inflammation, in murine models [26–30].
Lastly, curcumin suppresses both T cell and mast cell activation in culture, as well as IgE-
mediated mast cell degranulation and passive cutaneous anaphylaxis in mice [31, 32]. Taken
together, these data suggest that curcumin may have beneficial roles in Th2-driven diseases
and may prevent the development of allergy by suppressing Th2 and mast cell function, lead-
ing us to hypothesize that curcumin may also play a role in inhibiting the development of
food allergy in vivo.
Herein, we show that ingestion of curcumin inhibits both mast cell expansion and sup-
presses intestinal anaphylaxis in a murine model of OVA-induced food allergy. Oral allergen
challenge in sensitized BALB/c mice induced a robust IgE-mediated response accompanied by
enhanced OVA-IgE levels, intestinal mastocytosis, elevated serum murine mast cell protease-1
(mMCP-1) and acute diarrhea. In contrast, mice exposed to oral curcumin throughout the
experimental regimen did not exhibit allergic diarrhea or a significant enhancement of
OVA-IgE and intestinal mast cell expansion and activation. Furthermore, allergic diarrhea,
mast cell activation and expansion, as well as Th2 responses, were also suppressed in mice
exposed to curcumin during the challenge phase alone, despite the presence of OVA-IgE, sug-
gesting that curcumin may be pharmacologically therapeutic in previously sensitized allergic
individuals. Further analysis using both in vivo and in vitro experimental systems demon-
strated that the protective effects of curcumin were mediated by inhibition of mast cell
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expansion and activation, and that prolonged curcumin exposure induced the apoptosis of
mast cells in cell culture. Lastly, the attenuation of intestinal anaphylaxis in this model was
linked with the inhibition of nuclear factor-kappa B (NF-κB) activation, a well-established tar-
get of curcumin’s anti-inflammatory activity [29, 33]. Similarly, curcumin also inhibited the
phosphorylation of the p65 subunit of NF-κB in bone-marrow derived mast cells (BMMCs),
suggesting that the protective effects of curcumin during allergic responses may be mediated
by inhibiting NF-κB activation in activated intestinal mast cells.
Materials and Methods
Animals
BALB/c mice were purchased from Taconic Farms (Germantown, NY). All mice were 4 to 12
weeks old and all animal research was approved by the Institutional Animal Care and Use
Committee of Western New England University and received the approval number 2014-S1.
The research was conducted according to IACUC guidelines. Animals sacrificed for research
were euthanized using a compressed source of CO2 gas.
OVA sensitization and challenge protocol
To induce food allergy, BALB/c mice were intraperitoneally (i.p.) immunized with 50 μg
chicken egg ovalbumin (OVA) in 1 mg alum on days 0 and 14 as previously described [10, 34]
and depicted in Fig 1. Two weeks later, mice were challenged intragastrically (i.g.) with 50 mg
OVA in 250 μl phosphate buffered saline (PBS) once a day on 6 alternating days. One hour
after the 6th challenge, mice were sacrificed and the development of intestinal anaphylaxis was
ascertained using previously established procedures [10, 34].
Curcumin treatment
To determine whether curcumin inhibits the development of food allergy, OVA-primed and
challenged mice were gavaged with 300 μg curcumin (Sigma) in 1% carboxy methyl cellulose
(CMC) at various times as shown in Fig 1A–1C. Similarly, saline-sensitized, OVA-challenged
control mice were also treated with curcumin in 1% CMC. Exposure to oral CMC alone in
OVA-primed and challenged BALB/c mice has no effect on the development of intestinal ana-
phylaxis and mast cell activation (data not shown).
Measurement of intestinal anaphylaxis
Intestinal anaphylaxis was assessed in challenged mice by scoring the percentage of animals
exhibiting allergic diarrhea as previously described [10]. Briefly, mice were observed for the
presence of diarrhea for one hour after the 6th OVA-challenge and were scored as diarrhea-
positive or negative.
Histological analysis and enumeration of mast cells. Intestinal mast cells were enumer-
ated by microscopic examination of sections of paraffin-embedded jejunal tissue as previously
described [13]. Tissue sections were stained with chloroacetate esterase (CAE) and mast cells
were counted in complete cross-sections of jejunum as specified in the figure legends.
Quantitative PCR analysis and ELISAs
Quantitative real-time PCR was performed as previously described [13]. Expression of IL-4,
IL-5, IL-13, IL-9, IL-10, IL-17, IL-33, and IFN-γ was calculated relative to GAPDH transcripts.
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mMCP-1 (EBioscience) and OVA-IgE ELISAs were performed on serum samples as previously
described [13, 35].
BMMC culture
BMMC were generated, as previously described [36]. Briefly, marrow was obtained from the
femurs and tibiae of naive BALB/c mice, and cultured with 10 ng/ml IL-3 (Peprotech) and
10 ng/ml stem cell factor (SCF) (Peprotech) for 4–6 wks. Harvested BMMC were> 95% posi-
tive for c-Kit and FcεRI as detected by flow cytometry.
Fig 1. Curcumin treatment protocols. (A) Mice were gavaged with curcumin daily beginning one week prior
to sensitization and every other day after the 1st i.p. exposure. (B) Mice were gavaged with curcumin daily
only during the OVA-sensitization phase from days 1–14. (C) Mice were gavaged daily with curcumin during
the OVA-challenge phase alone. On days when mice received OVA treatment, curcumin was administered a
few minutes later, after all experimental mice received OVA.
doi:10.1371/journal.pone.0132467.g001
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Carboxyfluorescein succinimidyl ester (CFSE) labeling and transfer of
mast cells
CFSE labeling and mast cell adoptive transfer experiments were performed as previously
described [36]. Briefly, BMMC were treated with 5 μMCFSE in culture medium and incubated
at 37°C for 5 min without shaking. Approximately 1.0x106 labeled cells were injected i.p. into
BALB/c mice, and their expansion was followed for 6 days. A group of experimental mice was
gavaged daily with 300 μg curcumin during this period. On the 7th day, five experimental mice
from each group were sacrificed, and peritoneal cells were examined for the presence of CFSE+-
c-Kit+FcεRI+ cells using an Accuri C6 flow cytometer, and enumerated.
In vitro studies with curcumin
One million BMMCs were cultured in triplicate with IL-3 and SCF or 5 μg/ml DNP-IgE for 6
days. To determine the effects of curcumin on proliferating BMMCs, 30 μM curcumin was
added to the cells in dimethyl sulfoxide (DMSO) at the start of the culture. Control wells
received DMSO alone. The numbers of total cells/well were counted daily using trypan blue
exclusion. To assess the numbers of apoptotic cells, cells were stained with anti-Annexin V and
propidium iodide, and the numbers of c-Kit+FcεRI+ apoptotic cells were determined using an
apoptosis staining kit (EBioscience) by flow cytometry as previously described [36].
β-Hexosaminidase (β-hex) Assay
BMMCs were cultured in triplicate with IL-3 and SCF in the presence or absence of curcumin
for 24 h as described above. To induce activation, 2 μg/ml DNP-IgE was added to the cells. 24h
later, they were activated with 200 ng/ml DNP-BSA for 1h. β-hex activity was assessed as previ-
ously described [37]. Briefly, cells were washed and supernatants and pellets were collected.
Pellets were lysed with 0.5% Triton X-100. Both supernatants and pellets were then treated
with 4-nitrophenyl-N-acetyl-β-D-glucosaminide (p-NAG) substrate (Sigma) for 1h. Plates
were read at 405nm using a spectrophotometer to determine β-hex activity. Data are depicted
as percent of cell content demonstrating β-hex activity.
Assessment of NF-κB activation
Jejunae from experimental animals was fixed in 10% formalin, processed and embedded.
Immunohistochemistry for phospho-relA was performed on tissues as previously described
[33]. Tissues were sectioned at 4 μm on a graded slide, deparaffinized in xylene, rehydrated in
graded ethanols, and rinsed in Tris-phosphate-buffered saline (TBS). Heat-induced antigen
retrieval was performed in a microwave at 98°C in 0.01 M citrate buffer. Primary antibody
(p- NF-κB Santa Cruz Biotechnology (#sc-101749) 1:400) was exposed overnight followed by
secondary anti-rabbit antibody (DAKO (#K4003)). Immunoreactivity was visualized by incu-
bation with chromogen diaminobenzidine (DAB) for 5 minutes. Tissue sections were counter-
stained with hematoxylin, dehydrated through graded ethanols and xylene, and cover-slipped.
Western Blot
BMMCs were cultured with IL-3 and SCF in the presence or absence of curcumin for 24 h as
described above. To induce activation, 2 μg/ml DNP-IgE was added to the cells. 24h later, they
were activated with 200 ng/ml DNP-BSA for 12h. Whole cell extracts were obtained using
RIPA buffer containing 1% Triton X-100 and quantified with Coomassie Plus (Bradford) Pro-
tein Assay (Life Technologies). Equal amounts of protein were loaded onto 10% SDS-PAGE
gels and transferred to PVDF membrane. Membranes were blocked for one hour in 5% milk
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and incubated with primary antibodies (p- NF-κB (1:500) and Beta Actin (1:2000)) overnight.
Membranes were washed with PBS Tween 20 and incubated with appropriate secondary anti-
body. Membranes were washed a second time, incubated with chemiluminescent reagent (Cell
Signaling Technologies), and imaged with a Biorad Chemidoc. Quantification of western blot
data was completed using the Biorad Image Lab software. The Volume analysis tool was uti-
lized with local subtraction and resulting values for phospho-relA were divided by the values
quantifying beta-actin.
Statistical Analysis
Data are expressed as mean±SEM, unless stated otherwise. n = 5 mice/group unless indicated
otherwise. Statistical significance comparing different sets of mice (between 2 groups) was
determined by the Student’s t-test. In experiments comparing multiple experimental groups or
time points, two-way analysis of variance was performed and Bonferroni post-tests were used
to compare replicate means. P values of<0.05 were considered significant. Analysis was per-
formed using GraphPad Prism software and/or Microsoft Excel.
Results
Curcumin ingestion inhibits the development of intestinal anaphylaxis in
OVA-exposed mice
We chose to use a well-established model of intestinal anaphylaxis for our studies on the effects
of curcumin during allergic responses to food antigens [10, 34, 38]. This model provides a
unique system dependent on mast cells and IgE, and OVA-sensitized and challenged animals
develop profuse intestinal diarrhea, accompanied by edema and intestinal permeability.
Based on studies that curcumin inhibits T cell and mast cell functions, we hypothesized that
oral ingestion of curcumin during allergic sensitization and challenge would inhibit the devel-
opment of intestinal anaphylaxis to food antigens. In order to examine whether curcumin
inhibits intestinal anaphylaxis, mice were fed with 300 μg curcumin in 1% CMC daily, begin-
ning one week prior to the first OVA-alum i.p. challenge, and continued every other day
throughout the experimental protocol as depicted in Group 1 (Fig 1A). OVA-challenged
BALB/c mice produced elevated levels of OVA-specific IgE compared with saline-treated con-
trols. In contrast, the production of OVA-IgE in OVA-challenged, curcumin-treated mice was
significantly diminished (Fig 2A). Similarly, while OVA-sensitized and challenged BALB/c
mice exhibited severe profuse diarrhea compared with untreated controls (Fig 2B), none of the
OVA-exposed, curcumin-fed BALB/c mice exhibited diarrhea compared with the OVA-chal-
lenged, curcumin-untreated group. Likewise, during sacrifice, the production of intestinal
edema was also noted in several of the OVA-sensitized and challenged mice, but not in any
mice from the curcumin-treated group (data not shown). These data, therefore, suggest that
curcumin inhibits the development of IgE production and subsequent intestinal anaphylaxis to
oral allergens in this model.
Curcumin inhibits intestinal mastocytosis in allergic BALB/c mice
The development of allergic diarrhea in this model is dependent on mast cell activation [10]. In
light of the above observations, we therefore examined whether curcumin exposure also inhib-
its mast cell homeostasis in the intestines of allergic mice. Inspection for chloroacetate esterase
(CAE) reactivity in the jejunae of OVA-exposed BALB/c mice revealed the presence of numer-
ous mucosal mast cells in the villi compared with saline-exposed controls (Fig 2C). In contrast,
the numbers of mucosal mast cells were markedly reduced in OVA-exposed, curcumin-fed
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animals, suggesting that curcumin inhibits the development of mastocytosis in these animals.
In addition, elevated levels of mMCP-1, a marker that has been correlated with an activated
mast cell load in tissues, were found in the serum of OVA-challenged BALB/c mice compared
with saline controls (Fig 2D). In contrast, the production of this enzyme was decreased (except
for one outlier) in OVA-challenged, curcumin-treated mice. These data, therefore, suggest that
curcumin inhibits the development of mastocytosis in the intestines of allergic mice.
The expression of Th2 cytokines is diminished in curcumin-fed allergic
mice
In order to examine whether curcumin suppresses local Th2 responses in the intestines, the
jejunae of experimental animals was examined for the expression of the cytokines IL-4, IL-13,
IL-5, IL-9, IL-33, IL-10, IL-17, and IFN-γ. As expected, the expression of the classic Th2 cyto-
kines IL-4, IL-5, IL-13, IL-9, and IL-10 was significantly increased in the jejunum of OVA-chal-
lenged BALB/c mice compared with saline-treated controls. (Fig 3A–3D and 3F) In contrast,
Fig 2. Curcumin ingestion inhibits the development of intestinal anaphylaxis andmastocytosis in BALB/c mice.Mice were sensitized and
challenged with OVA and some mice were gavaged with curcumin as depicted in Fig 1A. (A) SerumOVA-IgE levels (1:50 dilution of serum was used for the
assay); (B) Percent of mice with diarrhea; (C) numbers of CAE+ jejunal mast cells; (D) and serummMCP-1 levels are shown. Data are representative of 3
independent experiments. ** = p<0.01
doi:10.1371/journal.pone.0132467.g002
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the expression of these cytokines was reduced in the intestines of OVA-challenged, curcumin-
treated animals (Fig 3A–3D and 3F). There were no differences in IL-33 or IFN-γ expression in
both groups (Fig 3E and 3H). Interestingly however, the increased expression of Th2 cytokines
induced by OVA-challenge was also accompanied by a decrease in the expression of the Th17
cytokine, IL-17, in allergic mice (Fig 3G). In contrast, no change in expression of IL-17 was
observed in the intestines of OVA-challenged, curcumin-treated mice as compared to saline-
sensitized, curcumin-treated control animals (Fig 3G). Taken together, these data suggest that
curcumin modulates the T cell response to oral antigen by skewing it away from a Th2-domi-
nated phenotype.
Oral curcumin ingestion during systemic allergen sensitization
attenuates allergic diarrhea but has modest effects on IgE production,
mast cell activation, and Th2 responses
The above observations demonstrate a role for curcumin in the inhibition of intestinal anaphy-
laxis, but it is not clear which aspects of the allergic response are specifically affected. Since
mice were exposed to curcumin prior to sensitization as well as throughout the experimental
protocol, it is possible that curcumin may have both prevented T cell sensitization to the aller-
gen, and/or inhibited subsequent Th2-dependent responses, including production of OVA-IgE
and IgE-dependent mast cell activation. Alternatively, it is possible that the inhibitory effects of
curcumin in our model are independent of T cells and are due to suppressive effects on mast
cell function during the acute phase of the response.
We therefore assessed whether ingestion of curcumin during OVA sensitization alone was
sufficient to inhibit the development of intestinal anaphylaxis. BALB/c mice were sensitized
and challenged with OVA, and some mice (Group 2) were gavaged with curcumin only prior
to and during OVA i.p. immunization as depicted in Fig 1B. Ingestion of curcumin during
sensitization alone did not attenuate the production of OVA-specific IgE antibodies in allergic
mice (Fig 4A). However, while curcumin-untreated, OVA-challenged mice exhibited severe
diarrhea in response to OVA challenge, the presence of diarrhea was not observed in the cur-
cumin-treated, OVA-challenged group (Fig 4B). Similarly, while the examination of CAE-
stained jejunal sections revealed that intestinal mast cell numbers tended to be lower in curcu-
min-treated mice, except for 1 mouse (Fig 4C), the levels of mMCP-1 were comparable in
both untreated and curcumin-treated mice, suggesting equivalent mast cell activation in both
groups (Fig 4D). Lastly, no significant differences in intestinal Th2 cytokine expression were
observed between both groups (Fig 5A–5H). These data, therefore, suggest that while curcu-
min ingestion during OVA-sensitization can attenuate allergic diarrhea and has some protec-
tive effects, its effects on antibody production, mast cell activation and Th2 responses is
limited, and not sufficient to deliver the full range of pharmacologic benefits as when given
during the entire immunization regimen, including both the priming and acute phases of the
model.
Curcumin ingestion during OVA-challenge alone is sufficient to inhibit
mast cell-dependent intestinal anaphylaxis despite the presence of
OVA-IgE
Mast cells and their mediators drive the acute phase of the response. Furthermore, the effects
of mast cells are IgE-dependent in this model [10]. Hence, while it is possible, that any inhibi-
tory effects of curcumin on mast cell activation observed in Groups 1 and 2 may actually be a
consequence of inhibition of Th2-dependent OVA-IgE responses, it is likely that curcumin
may also have a direct effect on mast cell proliferation and function during the effector phase
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Fig 3. Treatment with curcumin inhibits the expression of intestinal Th2 cytokines in allergic mice.Mice were fed with OVA and curcumin as depicted
in Fig 1A. (A-H) Expression of jejunal mRNA for various cytokines is shown. Data are representative of 2 independent experiments. * = p<0.05; ** = p<0.01.
doi:10.1371/journal.pone.0132467.g003
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of the disease. This is suggested by observations that curcumin inhibits mast cell activation
and function in cell culture [31, 32], and that it inhibits airway inflammation in a mast cell-
dependent model of asthma [29].
We therefore examined whether curcumin ingestion during OVA-challenge alone would
modulate the outcome of intestinal anaphylaxis in this model. Mice were sensitized and chal-
lenged with OVA, and some mice (Group 3) were treated with curcumin during the challenge
phase alone as depicted in Fig 1C. OVA-challenge induced the presence of OVA-IgE antibodies
in both untreated and curcumin-treated BALB/c mice (Fig 6A), suggesting that curcumin
ingestion during OVA-challenge has limited effects on development of Th2 cells and antibody
production. Surprisingly, despite the presence of similar OVA-IgE levels, the development of
allergic diarrhea was completely inhibited in curcumin-treated mice compared with untreated
controls (Fig 6B). Further examination revealed significantly decreased intestinal mast cell
numbers (Fig 6C), as well as decreased mast cell activation (Fig 6D), and Th2 cytokine mRNA
expression (Fig 7A–7H). These data, therefore, suggest that ingestion of curcumin during the
acute mast cell-dependent, OVA-challenge phase can directly modulate mast cell homeostasis
Fig 4. Curcumin exposure during sensitization alone attenuates allergic diarrhea but hasmodest effects on antibody production andmast cell
activation.Mice were fed with OVA and treated with curcumin during sensitization only as depicted in Fig 1B. (A) Levels of serum OVA-IgE (1:100 dilution of
serum was used for the assay); (B) Percent of mice with diarrhea; (C) Numbers of CAE+ mast cells; (D) and serummMCP-1 levels are shown.
doi:10.1371/journal.pone.0132467.g004
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Fig 5. Curcumin exposure during sensitization only results in modest attenuation of intestinal Th2 cytokines.Mice were fed with OVA and curcumin
as depicted in Fig 1B. (A-H) Expression of jejunal mRNA for various cytokines is shown.
doi:10.1371/journal.pone.0132467.g005
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and function independent of Th2 sensitization, resulting in the inhibition of mast cell-medi-
ated effects such as allergic diarrhea.
The expansion of adoptively transferred mast cells is inhibited in
curcumin-treated mice
Decreased numbers of mast cells in the intestines of curcumin-treated animals suggests that
curcumin blocks the homeostasis of these cells in vivo during food allergy. To assess whether
curcumin has a direct effect on mast cell expansion, we injected CFSE-labeled BMMCs into the
peritoneum of BALB/c mice, and followed their proliferation and survival for six days during
curcumin treatments. One week later, the peritoneal lavage was isolated and the numbers of
CFSE+-mast cells were assessed. As expected, the numbers of CFSE+ cells had doubled in the
peritoneum of untreated BALB/c mice (Fig 8A). In contrast, a similar expansion of CFSE+ cells
was not observed in curcumin-treated mice, and in some animals, the numbers of CFSE+ cells
had decreased from the original number that were injected (Fig 8A). These data suggest that
curcumin directly inhibits the expansion of mast cells in vivo.
Fig 6. Exposure to curcumin during OVA-challenge alone suppresses allergic diarrhea, andmast cell expansion and activation.Mice were fed with
OVA and treated with curcumin during OVA-challenge alone as depicted in Fig 1C. (A) Levels of serumOVA-IgE (1:50 dilution of serum was used for the
assay); (B) Percent of mice with diarrhea; (C) CAE+ mast cells; (D) and serummMCP-1 levels are shown. Data are representative of 3 independent
experiments. * = p<0.05; ** = p<0.01.
doi:10.1371/journal.pone.0132467.g006
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Fig 7. Curcumin treatment during OVA-challenge suppresses intestinal Th2 cytokine production.Mice were fed with OVA and curcumin as depicted
in Fig 1C. (A-H) Expression of jejunal mRNA for various cytokines is shown. Data are representative of 2 independent experiments. * = p<0.05; ** = p<0.01.
doi:10.1371/journal.pone.0132467.g007
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Curcumin inhibits the proliferation and survival of BMMCs and inhibits
their activation
Since curcumin had such a profound effect in inhibiting the development of mastocytosis in
vivo, we decided to study its effects in vitro on the proliferation and survival of BMMCs.
BMMCs were cultured with either IL-3 and SCF or DNP-IgE, and their survival was followed
as previously described [37, 39]. Strikingly, curcumin completely inhibited the proliferation
and survival of BMMCs over a period of 6 days (Fig 8B). Apoptosis studies revealed increased
numbers of AnnexinV+ cells in cultures treated with curcumin compared to those treated with
vehicle alone (Fig 8C), suggesting that curcumin has the potential to induce apoptosis in
allergen-sensitized BMMCs in vivo and curb their expansion. The β-hex assay was performed
to assess the extent of degranulation of activated mast cells. Activated BMMCs exhibited ele-
vated levels of β-hex compared with inactivated controls (Fig 8D). In contrast, treatment with
curcumin not only inhibited increases in the levels of β-hex in activated BMMCs, but also sup-
pressed them in IgE-primed, non-activated controls (Fig 8D). The specific release of β-hex was
also inhibited by curcumin (data not shown). These data, therefore, confirm the inhibitory
effects of curcumin on mast cells observed in the food allergy model, and suggest that its pro-
tective effect is mediated by suppression of activated mast cells.
Fig 8. Curcumin inhibits the expansion of mast cells in vivo and inhibits their proliferation, survival and activation in vitro. (A) CFSE+ BMMCs in the
peritoneum of curcumin-gavaged mice. (B-D) BMMCs were cultured in the presence of IL-3 and SCF or DNP-IgE with or without 30 μM curcumin for 6 days.
Data are representative of 3 or more independent experiments. (B) Numbers of BMMCs; (C) Percentages of apoptotic BMMCs; (D) and assessment of β-hex
activity is shown. * = p<0.05 and ** = p<0.01 by Students t-test. † = p<0.0001 and ‡ = p<0.0005 by ANOVA.
doi:10.1371/journal.pone.0132467.g008
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Treatment of allergic mice with curcumin inhibits the activation of NF-κB
in intestinal tissue
A number of studies indicate that curcumin is a potent non-specific inhibitor of the transcrip-
tion factor NF-κB [40–42], which is involved in the activation of both T and mast cells. To
determine whether curcumin inhibits NF-κB activation in this model, we assessed the activa-
tion of NF-κB in the intestinal tissues of allergic mice (Fig 9A). The p65 (RelA) sub-unit of NF-
κB plays a crucial role in the activation of NF-κB and its phosphorylation at Ser276 (phospho-
relA staining) can be assessed by immunohistochemistry as previously described [33]. While
the intestinal tissue of saline-sensitized and OVA-challenged control mice did not exhibit sig-
nificant phospho-relA staining, the number of phospho-relA+ cells (including mast cells as
assessed by morphologic analysis) in the intestines of OVA-sensitized and challenged mice was
dramatically increased, suggesting that the induction of allergic responses is accompanied by
NF-κB activation. In contrast, the intestines of OVA-exposed, curcumin-treated mice appeared
to be similar to those of saline-treated controls suggesting that curcumin inhibits the activation
of NF-κB. These data, therefore, suggest that the inhibitory effects of curcumin on mast cells in
our model may be conferred by blocking the activation of NF-κB.
Fig 9. Treatment of allergic mice with curcumin inhibits the activation of NF-κB. (A) Mice were fed with OVA and curcumin and sacrificed as depicted in
Fig 1C. Immunohistochemistry on jejunal sections was performed as described in Materials and Methods. Phospho-relA staining (brown) in jejunal tissue is
shown. Phospho-relA-positive mast cells as assessed by morphologic analysis are depicted by red arrows. (B) BMMCs were cultured with or without
DNP-IgE and 30 μM curcumin in DMSO and activated in the presence of antigen 24 hours later. 12 hours later, protein was extracted from whole cell lysates
andWestern blot was performed. Data are representative of three experiments. (C) Quantification of the Western Blot data from B is shown.
doi:10.1371/journal.pone.0132467.g009
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Curcumin treatment inhibits the phosphorylation of NF-κB p65 in
activated BMMCs
To further assess the effects of curcumin on NF-κB activation in mast cells, we examined the
presence of NF-κB p65 (phospho-relA) phosphorylation in BMMCs activated by cross-linking
via the IgE receptor and antigens. While activated BMMCs clearly exhibited the phosphoryla-
tion of the p65 subunit at Ser276, decreased phosphorylation was observed in BMMCs that had
been pre-treated with curcumin prior to activation with antigen. Similarly, a decrease in phos-
phorylation was also observed in curcumin-treated inactivated controls (Fig 9B and 9C).
Taken together, these data therefore indicate that the effects of curcumin on mast cell activa-
tion and function during allergic responses in vivomay be mediated by the inhibition of NF-
κB activation in mast cells.
Discussion
Food allergy is a growing health problem, especially in Western countries, where it has a signif-
icant impact on the health and daily activities of allergic individuals. The findings reported
here indicate that dietary components such as curcumin, with established anti-inflammatory
and anti-allergic activity, can significantly modulate the mucosal immune response and may
thus have therapeutic consequences in patients with food allergies.
Numerous scientific studies show beneficial roles for curcumin and it has been investigated
as a therapeutic agent in clinical trials for several diseases, including ulcerative colitis [43],
inflammatory bowel disease [44], Alzheimer’s [45], and cancer [46]. Curcumin’s effects on the
immune system are manifold, and are consistent with its broad pharmacological effects, such
as the inhibition of NF-κB, which is involved in the activation of many immune cells. Here, we
show that ingestion of curcumin during allergic sensitization and challenge abrogates the
development of intestinal anaphylaxis, and inhibits mast cell activation and Th2 responses dur-
ing food allergy. Furthermore, the protective effects of curcumin were observed in previously
sensitized mice and reversed the development of food allergy in allergic mice despite the pres-
ence of OVA-IgE antibodies, suggesting a strong potential for therapeutic use of curcumin in
allergic patients.
The suppression of polyclonal T cell activation by curcumin has been observed in many dis-
ease models [21], and we therefore anticipated that curcumin exposure would inhibit Th2-de-
pendent effects, such as the production of OVA-specific IgE antibodies and the subsequent
development of IgE-dependent, mast cell-mediated intestinal anaphylaxis. However, whether
the observed effects of suppression of intestinal anaphylaxis were specifically due to inhibitory
effects of curcumin on Th2 cells or mast cells was not clear. While curcumin ingestion during
OVA sensitization attenuated allergic diarrhea and OVA-IgE, consistent with its effects on sup-
pression of T cells, the effects were modest, and a complete inhibition of the allergic response
in terms of mast cell-mediated effects was not observed. This, therefore, suggested that while
curcumin has limited effects on allergic sensitization, its protective effects may be conferred
during re-exposure to the allergen during the acute phase. Surprisingly, examination of mice
treated with curcumin during the acute, OVA-challenge phase, demonstrated a complete atten-
uation of allergic diarrhea, as well as mast cell activation and Th2 responses. Moreover, inhibi-
tion of the allergic response was observed despite the presence of OVA-specific IgE antibodies.
These data, therefore, suggested that the inhibitory effects of curcumin may be a conse-
quence of direct suppression of mast cell activation and function in allergic mice. This was cor-
roborated by observations that the expansion of adoptively transferred BMMCs is limited in
the peritoneum of curcumin-treated mice, and that curcumin inhibits the proliferation and
survival of BMMCs in vitro, and induces their apoptosis. Furthermore, curcumin may also
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affect mast cell function during allergic responses. Our data demonstrates that curcumin can
inhibit mast cell degranulation, as indicated by the release of β-hex, and Lee et al. demonstrated
that curcumin can inhibit the production of IL-4 and TNF-α by RBL cells [32]. This is consis-
tent with our observations demonstrating the decreased mRNA expression of IL-4 and other
Th2 cytokines in the intestines of curcumin-treated animals.
The decreased activation of mast cells in OVA-challenged, curcumin-treated mice during
the challenge phase, despite the presence of elevated levels of IgE antibodies, suggests that the
suppression of mast cell function by curcumin may occur by affecting targets downstream of
the antigen:IgE:FcεRI signaling cascade, and/or as a result of blockade of calcium mobilization
as has been previously shown in T cells [47], Our data showing that activation of NF-κB is
inhibited in curcumin-treated mice and in BMMCs, is consistent with effects on the signaling
pathway, and may directly explain the effects of curcumin on mast cell responses in the model.
Additionally, Lee et al. demonstrated that the inhibitory effects of curcumin on mast cell activa-
tion in vitro were due to the inhibition of Syk kinase activity (which likely occurs upstream of
NF-κB signaling in mast cells) [32], suggesting that similar effects may also be mediated by cur-
cumin in allergic mice during food allergy. In this context, a recent paper demonstrating that
the pharmacologic blockade of Syk reversed the establishment of food allergy [48], confirms
that oral treatment aimed at inhibiting Syk activity can ameliorate allergic responses, and sug-
gests that this may be a highly plausible mechanism by which curcumin suppresses mast cell
expansion and activation during allergic responses. Lastly, curcumin is known to have a range
of pharmacological targets, and its effects on other immune cell types, such as dendritic cells
[49] and regulatory T cells [50], may also be important and warrant further investigation in the
examination of food-induced allergic responses. In this context, whether curcumin may affect
the absorption of OVA by antigen-presenting cells as well as other intestinal cells is also an
important question that needs to be further investigated.
In summary, we report novel findings on the anti-allergic effects of a natural dietary com-
pound, curcumin, which may have the potential for therapeutic use in patients with food
allergy. Curcumin and its derivatives are already being used in clinical trials, and analogs with
better bioavailability could be developed that are more effective in patients with food allergy
[19]. Furthermore, our data demonstrates novel inhibitory effects of curcumin on mast cell
activation and intestinal anaphylaxis, thus providing further insight into the mechanism by
which this natural compound regulates allergic responses. Lastly, our data indicate that dietary
substances such as curcumin, which is a daily component of the diet of some countries, have
the potential to regulate mucosal immune responses, warranting further investigation into the
association between dietary factors and the development of food allergy in nations with higher
prevalence of the disease.
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